![Guo-Liang Yu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Guo-Liang Yu
Fondatore presso
Immune-Onc Therapeutics, Inc.
Profilo
Guo-Liang Yu is the founder of QuanDx, Inc., founded in 2012.
Dr. Yu was the founder of Epitomics, Inc., founded in 2001, and served as Chairman, President & Chief Executive Officer.
Dr. Yu was the founder of Apollomics, Inc. (United States), founded in 2015, and held the title Chairman & Chief Executive Officer.
Dr. Yu is the founder of Immune-Onc Therapeutics, Inc., founded in 2016, serving as Director.
Dr. Yu is the founder of Innoforce Pharmaceuticals Co. Ltd., founded in 2018, serving as Chairman.
Dr. Yu is also the founder of NVIGEN, Inc.,The Chinese Biopharmaceutical Association..
Dr. Yu is Chairman at The BayHelix Group since 2022.
Dr. Yu is Chairman at Zhejiang Crownmab Biotech Co. Ltd. since 2018.
Dr. Yu is Director at the University of the Pacific.
Dr. Yu is Director at National Foundation for Cancer Research.
Dr. Yu is Director at The Chinese-American Biopharmaceutical Society.
Dr. Yu is Director at Alpine BioTherapeutics Corp.
Dr. Yu is Director at Maijin Biomedical Technology (Shanghai) Co., Ltd. since 2020.
Dr. Yu is Director at Zhejiang Innoforce Pharmaceuticals Co., Ltd. Dr. Yu is Venture Partner at OrbiMed Advisors Private Equity.
Former positions include Chairman & Chief Technology Officer at Crown Bioscience International from 2013 to 2018.
Chairman at Qyuns Therapeutics Co., Ltd. in 2015.
Executive Chairman & Chief Technology Officer at Crown Bioscience, Inc. from 2013 to 2018.
Director at Applied StemCell, Inc. Director at Ray Wu Memorial Fund from 2013 to 2015.
Independent Director at PlexBio Co., Ltd. from 2018 to 2020.
Senior Scientist at Human Genome Sciences, Inc. Senior Vice President-Research & Development at Mendel Biotechnology, Inc. Education includes a doctorate from the University of California, Berkeley in 1990 and an undergraduate degree from Fudan University in 1984.
Posizioni attive di Guo-Liang Yu
| Società | Posizione | Inizio |
|---|---|---|
The BayHelix Group
 The BayHelix Group Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit professional organization | Presidente | 01/01/2022 |
The Chinese-American Biopharmaceutical Society
 The Chinese-American Biopharmaceutical Society Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Direttore/Membro del Consiglio | - |
National Foundation for Cancer Research
 National Foundation for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research and development of cancer treatments | Direttore/Membro del Consiglio | - |
University of the Pacific
 University of the Pacific Other Consumer ServicesConsumer Services Functions as a College/University | Direttore/Membro del Consiglio | - |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Investitore di Private Equity | - |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Develops mono therapies and combination therapies of tumor-targeting and immuno-oncology agents | Amministratore Delegato | 16/08/2018 |
Immune-Onc Therapeutics, Inc.
 Immune-Onc Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company advancing novel therapies that target myeloid cells | Fondatore | 01/01/2016 |
Alpine BioTherapeutics Corp.
 Alpine BioTherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a technology that prevents and reverses the death of cells in the ocular cell system | Direttore/Membro del Consiglio | - |
Zhejiang Crownmab Biotech Co. Ltd. | Presidente | 29/05/2018 |
| ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Precedenti posizioni note di Guo-Liang Yu
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Guo-Liang Yu
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
75
Relazioni di 1° grado
27
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 27 |
|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Epitomics, Inc.
 Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody technology used for research and diagnostics | Health Technology |
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a global contract research organization for drug discovery | Commercial Services |
Applied StemCell, Inc.
 Applied StemCell, Inc. BiotechnologyHealth Technology Operates as a holding company whose subsidiaries engages in cell and gene therapy development research | Health Technology |
NVIGEN, Inc.
 NVIGEN, Inc. Medical SpecialtiesHealth Technology Develops nanoparticle research reagents and devices for biomedical research applications | Health Technology |
QuanDx, Inc.
 QuanDx, Inc. Medical SpecialtiesHealth Technology Manufactures molecular diagnostic kits, assays and instruments | Health Technology |
Mendel Biotechnology, Inc.
 Mendel Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Develops genetic and chemical solutions for the agricultural markets | Commercial Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Pacific
University of the Pacific Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fudan University
 Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
National Foundation for Cancer Research
National Foundation for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research and development of cancer treatments | Commercial Services |
The BayHelix Group
The BayHelix Group Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit professional organization | Commercial Services |
The Chinese Biopharmaceutical Association | |
The Chinese-American Biopharmaceutical Society
The Chinese-American Biopharmaceutical Society Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Health Technology |
Ray Wu Memorial Fund
 Ray Wu Memorial Fund The Ray Wu Memorial Fund honors Dr. Ray Wu, a life sciences scholar known for developing the first DNA sequencing method and advancing recombinant DNA technology. The private company is based in Birmingham, AL. The fund promotes scientific exchange and supports the CBEA program, which has enabled over 400 Chinese students to pursue Ph.D. studies. It annually awards the Ray Wu Prize to outstanding Ph.D. students in life sciences from mainland China, recognizing innovation, independent thinking, and dedication. The prize includes monetary awards, a medal, certificate, citation, travel support for conferences, and mentorship opportunities. The fund also acknowledges Prof. Gu Xiaocheng for her leadership in life sciences and her role in fostering scientific exchange and student support. | |
Crown Bioscience International
 Crown Bioscience International BiotechnologyHealth Technology Operates as a biotechnology company that develops drug for oncology and metabolic diseases | Health Technology |
PlexBio Co., Ltd.
 PlexBio Co., Ltd. Medical SpecialtiesHealth Technology Engages in design, develop and manufacture of IVD product & instrument | Health Technology |
Apollomics, Inc. (United States)
Apollomics, Inc. (United States) BiotechnologyHealth Technology Develops mono therapies and combination therapies of tumor-targeting and immuno-oncology agents | Health Technology |
Immune-Onc Therapeutics, Inc.
Immune-Onc Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company advancing novel therapies that target myeloid cells | Health Technology |
Qyuns Therapeutics Co., Ltd.
 Qyuns Therapeutics Co., Ltd. BiotechnologyHealth Technology Engages in research and development, manufacturing & sale of biologic therapies for autoimmune and allergic diseases | Health Technology |
Zhejiang Crownmab Biotech Co. Ltd. | |
Alpine BioTherapeutics Corp.
Alpine BioTherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a technology that prevents and reverses the death of cells in the ocular cell system | Commercial Services |
Maijin Biomedical Technology (Shanghai) Co., Ltd.
 Maijin Biomedical Technology (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs related to immunology | Commercial Services |
Zhejiang Innoforce Pharmaceuticals Co., Ltd.
 Zhejiang Innoforce Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
Innoforce Pharmaceuticals Co. Ltd.
 Innoforce Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes biopharmaceuticals | Health Technology |
Apollomics, Inc.
 Apollomics, Inc. Financial ConglomeratesFinance Operates as a biotechnology company that focuses on development of novel medicines for cancer patients | Finance |
